DocketTrail

Inform Diagnostics / Fulgent - Bako Pathology

OR CA · Latest: OR Preliminary review completed

Agency description

Inform Diagnostics, Inc. and Fulgent Therapeutics, LLC will acquire equity interests of Dermatopathology Experts, LLC and all assets related to the diagnostic and therapeutic services of Bako Pathology Holdings Corp. and its subsidiaries.

CA Office of Health Care Affordability (HCAI), “Transaction Type” column, hcai.ca.gov

State reviews

StateAgencyStatusStageSource
OROregon Health AuthorityApproved APPROVEDPreliminary Review PRELIMINARYAgency record
CAOffice of Health Care Affordability (HCAI)CMIR Waived WAIVEDNOTICEAgency record

Trail

Dates as published by the agency unless marked.

  1. CA Notice complete
    Date Submission Completed: January 7, 2026
  2. OR Preliminary review completed
    OHA completed a 30-day preliminary review of this transaction on March 16, 2026.

Not dated

  1. CA Cost and market impact review waived
    CMIR Waived

Changes

Feed

No changes observed since the initial load (OR · CA ).

About the digest

Parties as filed

Documents (23)
Evidence

Grouped by DocketTrail's reviewed seed list, entry inform-diagnostics-fulgent-bako-pathology.

Names as filed and source keys

StateTitle as printedSource keyKey method
OR072 InformDx - Bako Pathology072AGENCY_NUMBER
CAInform Diagnostics, Inc. / and / Fulgent Therapeutics, LLCmcn-inform-diagnosticsFIRST_DOCUMENT_SLUG

Observed by DocketTrail

StateSource keyFirst seen by DocketTrail (UTC)Last checked (UTC)Page checked
OR072oregon.gov
CAmcn-inform-diagnosticshcai.ca.gov

Captures